Among patients with resectable non-small cell lung cancer, Opdivo plus Yervoy has displayed potential long-term clinical ...

The film discusses the pressures on teenagers to smoke and the associated health risks, particularly lung cancer and heart ...

Diagnosing patients when there aren’t effective treatments to give them can make their symptoms worse, argues neurologist ...

The researchers found that factors favoring chemoimmunotherapy included higher socioeconomic status, being uninsured, a more ...

Patients who receive certain cancer treatments are at greater risk of secondary malignancies and must be educated accordingly ...

Can a drug that's used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have ...

People who land in the ER after using hallucinogens are more than twice as likely to die in a handful of years, a new study ...

People who land in the ER after using hallucinogens are more than twice as likely to die in a handful of years, a new ...

A woman with terminal lung cancer has said she feels "scared" of dying at home rather than in the care of a specialist ...

More than a decade after Merck’s Keytruda and BMS’ Yervoy ushered in the immuno-oncology revolution, the space is at a ...

WHEN Kerrie Mitchell found a lump just beneath her neck, she never imagined it could be lung cancer. For at 46, the busy working mum felt as fit as a fiddle and brushed the thought of it aside ...

For terminally ill cancer patients, the final days of life are immensely personal, having the choice to continue cancer ...